Quadrant Capital Group’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$433	Sell	141 -649	-82%	-$2.81K	﹤0.01%	2634
2025 Q4	$2.81K	Sell	790 -1,061	-57%	-$6.5K	﹤0.01%	2462
2025 Q3	$16.5K	Buy	+1,851	New	+$18.8K	﹤0.01%	2007
2025 Q2	–	Sell	-2,611	Closed	-$22.4K	–	1452
2025 Q1	$22.4K	Buy	2,611 +450	+21%	+$4.25K	﹤0.01%	2007
2024 Q4	$23.2K	Buy	2,161 +649	+43%	+$4.99K	﹤0.01%	1824
2024 Q3	$8.59K	Hold	1,512	–	–	﹤0.01%	2184
2024 Q2	$6.38K	Buy	+1,512	New	+$6.12K	﹤0.01%	2237
2024 Q1	–	Sell	-86	Closed	-$801	–	2721
2023 Q4	$801	Buy	+86	New	+$592	﹤0.01%	2573
2018 Q1	–	Sell	-1,705	Closed	-$5K	–	2160
2017 Q4	$5K	Hold	1,705	–	–	﹤0.01%	1446
2017 Q3	$7K	Hold	1,705	–	–	﹤0.01%	1318
2017 Q2	$9K	Hold	1,705	–	–	﹤0.01%	1132
2017 Q1	$9K	Hold	1,705	–	–	﹤0.01%	1102
2016 Q4	$6K	Buy	+1,705	New	+$6.07K	﹤0.01%	1175